Found 7 matching trials
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma PHASE1 This phase 1 study will investigate the safety, tolerability, pharmacokinet...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies PHASE1 The purpose of this study is to assess the safety and efficacy of surovatam...
Show More Learn More & Join Trial
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL PHASE3 The purpose of this study is to measure the efficacy and safety of R-mini-C...
Show More Learn More & Join Trial
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia PHASE1 This is a Phase 1/2, global multicentre, open-label, single-arm, dose escal...
Show More Learn More & Join Trial
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients PHASE3 This is a global, randomised, Phase III, multicentre, open-label study eval...
Show More Learn More & Join Trial
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL PHASE2 This is a Phase 2 global, multi-center, open-label study to assess the effi...
Show More Learn More & Join Trial
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV) PHASE3 The purpose of this study is to evaluate the therapeutic benefit and safety...
Show More Learn More & Join Trial